This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.
Barjon K, Mikhail LN. Uterine leiomyomata (fibroids). In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK546680 [Last accessed on 2020 Oct 16].Search in Google Scholar
Williams AR. Uterine fibroids – what’s new? F1000Res. 2017;6:2109. https://doi.org/10.12688/f1000research.12172.1 PMid:29259779Search in Google Scholar
Tanos V, Berry KE, Frist M, Campo R, DeWilde RL. Prevention and management of complications in laparoscopic myomectomy. Biomed Res Int. 2018;2018:8250952. https://doi.org/10.1155/2018/8250952 PMid:29693017Search in Google Scholar
Fletcher H, Frederick J, Hardie M, Simeon D. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol. 1996;87(6):1014-8. https://doi.org/10.1016/0029-7844(96)00071-3 PMid:8649682Search in Google Scholar
Frederick J, Fletcher H, Simeon D, Mullings A, Hardie M. Intramyometrial vasopressin as a haemostatic agent during myomectomy. Br Int J Obstet Gynaecol. 1994;101(5):435-7. https://doi.org/10.1111/j.1471-0528.1994.tb11918.x PMID: 8018617Search in Google Scholar
Saha MM, Khushboo, Biswas SC, Alam H, Kamilya GS, Mukhopadhyay M, et al. Assessment of blood loss in abdominal myomectomy by intramyometrial vasopressin administration versus conventional tourniquet application. J Clin Diagn Res. 2016;10(5):QC10-3. https://doi.org/10.7860/JCDR/2016/17484.7789 PMid:27437308Search in Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009;339:b2535. https://doi.org/10.1136/bmj.b2535 PMid:19622551Search in Google Scholar
Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Oxford Centre for Evidence-Based Medicine: Levels of Evidence (March 2009). Oxford: Centre for Evidence-Based Medicine (CEBM); 1998. Available from: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009 [Last accessed on 2020 Oct 17].Search in Google Scholar
Ginsburg ES, Benson CB, Garfield JM, Gleason RE, Friedman AJ. The effect of operative technique and uterine size on blood loss during myomectomy: A prospective randomized study. Fertil Steril. 1993;60(6):956-62. https://doi.org/10.1016/s0015-0282(16)56392-4 PMid:8243699Search in Google Scholar
Protopapas A, Giannoulis G, Chatzipapas I, Athanasiou S, Grigoriadis T, Kathopoulis N, et al. Vasopressin during laparoscopic myomectomy: Does it really extend its limits? J Minim Invasive Gynecol. 2018;26(3):441-9. https://doi.org/10.1016/j.jmig.2018.05.011 PMid:29778690Search in Google Scholar
Sapmaz E, Çelik H. Comparison of the effects of the ligation of ascending branches of bilateral arteria uterina with tourniquet method on the intra-operative and post-operative hemorrhage in abdominal myomectomy cases. Eur J Obstet Gynecol Reprod Biol. 2003;111(1):74-7. https://doi.org/10.1016/s0301-2115(03)00207-0 PMid:14557016Search in Google Scholar
Dillon TF. Vasopressin as a hemostatic in gynecologic surgery. Am J Obstet Gynecol. 1959;78(6):1285-91. https://doi.org/10.1016/0002-9378(59)90591-5 PMid:13816786Search in Google Scholar
Cohen SL, Senapati S, Gargiulo AR, Srouji SS, Tu FF, Solnik J, et al. Dilute versus concentrated vasopressin administration during laparoscopic myomectomy: A randomised controlled trial. BJOG. 2016;124(2):262-8. https://doi.org/10.1111/1471-0528.14179 PMid:27362908Search in Google Scholar
Taylor A, Sharma M, Tsirkas P, Di Spiezio Sardo A, Setchell M, Magos A. Reducing blood loss at open myomectomy using triple tourniquets: A randomised controlled trial. BJOG. 2005;112(3):340-5. https://doi.org/10.1111/j.1471-0528.2004.00430.x PMid:15713151Search in Google Scholar
Kathiresan AS, Brookfield KF, Gonzalez-Quintero VH, Verma U. Vasopressin versus a combination of vasopressin and tourniquets: A comparison of blood loss in patients undergoing abdominal myomectomies. Aust N Z J Obstet Gynaecol. 2010;51(1):79-83. https://doi.org/10.1111/j.1479-828x.2010.01253.x PMid:21299514Search in Google Scholar
Agida ET, Isah AD, Isah AY. Intramyometrial vasopressin for reducing blood loss at myomectomy. Ann Med Health Sci Res. 2020;10:857-64.Search in Google Scholar
Chilkoti G, Mohta M, Nath S, Saxena AK, Khurana P. Anaesthetic concerns with intramyometrial vasopressin during myomectomy. Ain-Shams J Anaesthesiol. 2016;9:452-4. https://doi.org/10.4103/1687-7934.189089Search in Google Scholar
Sanyal U, Ghosh S, Hiremath PB, Hiremath R The role of tourniquet in myomectomy: An observational study. Int J Reprod Contracept Obstet Gynecol. 2019;8(4):1610-5. https://doi.org/10.18203/2320-1770.ijrcog20191227Search in Google Scholar
Kongnyuy EJ, van den Broek N, Wiysonge CS. A systematic review of randomized controlled trials to reduce hemorrhage during myomectomy for uterine fibroids. Int J Gynecol Obstet. 2007:100(1);4-9. https://doi.org/10.1016/j.ijgo.2007.05.050 PMid:17894936Search in Google Scholar
Ikechebelu JI, Eczema CO, Obiechina NJ. The use of tourniquet to reduce blood loss at myomectomy. Niger J Clin Pract. 2010;13(2):154-8. PMid:20499747Search in Google Scholar